Author:
Florian Stefan,Mitchison Timothy J.
Reference98 articles.
1. Caner JE (1965) Colchicine inhibition of chemotaxis. Arthritis Rheum 8(5):757–764
2. Xi J, Zhu X, Feng Y et al (2013) Development of a novel class of tubulin inhibitors with promising anticancer activities. Mol Cancer Res 11(8):856–864. doi: 10.1158/1541-7786.MCR-12-0177
3. Rowinsky EK (2011) Antimitotic Drugs. In: Chabner BA, Longo DL (eds) Cancer Chemotherapy and Biotherapy: Principles and Practice. Lippincott Williams & Wilkins, Philadelphia, p 848
4. Fujikawa-Yamamoto K, Teraoka K, Zong ZP et al (1994) Apoptosis by demecolcine in V79 cells. Cell Struct Funct 19(6):391–396
5. Lin CM, Singh SB, Chu PS et al (1988) Interactions of tubulin with potent natural and synthetic analogs of the antimitotic agent combretastatin: a structure-activity study. Mol Pharmacol 34(2):200–208
Cited by
145 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献